These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36728526)

  • 1. Tofacitinib in Ulcerative Colitis-evolving Efficacy and Safety.
    Tiwari A; Ashraf A; Bharali P
    J Clin Gastroenterol; 2023 Apr; 57(4):429. PubMed ID: 36728526
    [No Abstract]   [Full Text] [Related]  

  • 2. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    Sandborn WJ; Su C; Sands BE; D'Haens GR; Vermeire S; Schreiber S; Danese S; Feagan BG; Reinisch W; Niezychowski W; Friedman G; Lawendy N; Yu D; Woodworth D; Mukherjee A; Zhang H; Healey P; Panés J;
    N Engl J Med; 2017 May; 376(18):1723-1736. PubMed ID: 28467869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.
    Sands BE; Armuzzi A; Marshall JK; Lindsay JO; Sandborn WJ; Danese S; Panés J; Bressler B; Colombel JF; Lawendy N; Maller E; Zhang H; Chan G; Salese L; Tsilkos K; Marren A; Su C
    Aliment Pharmacol Ther; 2020 Jan; 51(2):271-280. PubMed ID: 31660640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses.
    Pantavou K; Yiallourou AI; Piovani D; Evripidou D; Danese S; Peyrin-Biroulet L; Bonovas S; Nikolopoulos GK
    United European Gastroenterol J; 2019 Dec; 7(10):1285-1303. PubMed ID: 31839954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated Tuberculosis in a Patient Treated with Tofacitinib for Ulcerative Colitis.
    Charpy F; Altwegg R; Debourdeau A
    J Crohns Colitis; 2022 May; 16(4):685-686. PubMed ID: 34752607
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Winthrop KL; Melmed GY; Vermeire S; Long MD; Chan G; Pedersen RD; Lawendy N; Thorpe AJ; Nduaka CI; Su C
    Inflamm Bowel Dis; 2018 Sep; 24(10):2258-2265. PubMed ID: 29850873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trial.
    Mukherjee A; Hazra A; Smith MK; Martin SW; Mould DR; Su C; Niezychowski W
    Br J Clin Pharmacol; 2018 Jun; 84(6):1136-1145. PubMed ID: 29377257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib.
    Tassone D; Singh S; Sheng Ding N
    Aliment Pharmacol Ther; 2021 Jul; 54(2):206-207. PubMed ID: 34170531
    [No Abstract]   [Full Text] [Related]  

  • 9. In brief: Risk of pulmonary thromboembolism and death with tofacitinib.
    Med Lett Drugs Ther; 2019 Aug; 61(1579):136. PubMed ID: 31581159
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and safety of tofacitinib in ulcerative colitis: Done is better than perfect.
    Katsanos KH; Armuzzi A
    Dig Liver Dis; 2022 Feb; 54(2):151-153. PubMed ID: 34953762
    [No Abstract]   [Full Text] [Related]  

  • 11. Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore.
    Lee SD; Allegretti JR; Steinwurz F; Connelly SB; Lawendy N; Paulissen J; Gecse KB
    BMC Gastroenterol; 2023 Feb; 23(1):34. PubMed ID: 36755231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
    Weisshof R; Aharoni Golan M; Sossenheimer PH; El Jurdi K; Ollech JE; Pekow J; Cohen RD; Sakuraba A; Dalal S; Rubin DT
    Dig Dis Sci; 2019 Jul; 64(7):1945-1951. PubMed ID: 30734234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and safety of tofacitinib in ulcerative colitis.
    López-Sanromán A; Esplugues JV; Domènech E
    Gastroenterol Hepatol; 2021 Jan; 44(1):39-48. PubMed ID: 32829958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis.
    Sandborn WJ; Armuzzi A; Liguori G; Irving PM; Sharara AI; Mundayat R; Lawendy N; Woolcott JC; Danese S
    Inflamm Bowel Dis; 2022 Sep; 28(9):1338-1347. PubMed ID: 34958359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
    Sandborn WJ; Panés J; Sands BE; Reinisch W; Su C; Lawendy N; Koram N; Fan H; Jones TV; Modesto I; Quirk D; Danese S
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1068-1076. PubMed ID: 31599001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.
    Jacobs J; Clark-Snustad K; Lee S
    Inflamm Bowel Dis; 2020 Jun; 26(7):e64. PubMed ID: 32342098
    [No Abstract]   [Full Text] [Related]  

  • 17. An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States.
    Milev S; DiBonaventura MD; Quon P; Wern Goh J; Bourret J; Peeples-Lamirande K; Soonasra A; Cappelleri JC; Quirk D
    J Med Econ; 2019 Sep; 22(9):859-868. PubMed ID: 31012362
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of tofacitinib treatment in ulcerative colitis.
    Panés J; Gisbert JP
    Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
    Sandborn WJ; Peyrin-Biroulet L; Sharara AI; Su C; Modesto I; Mundayat R; Gunay LM; Salese L; Sands BE
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):591-601.e8. PubMed ID: 33684552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: real-world safety of tofacitinib in ulcerative colitis.
    Taxonera C
    Aliment Pharmacol Ther; 2022 Feb; 55(3):368-369. PubMed ID: 35040163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.